Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-12-001497
Filing Date
2012-01-06
Accepted
2012-01-06 14:41:58
Documents
1
Period of Report
2011-12-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 5541
  Complete submission text file 0001140361-12-001497.txt   6869
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address
Chatfield Steven (Reporting) CIK: 0001380176 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33137 | Film No.: 12514173